Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,126.00    -32.00 (-1.48%)
Bid:
2,130.00
Ask:
2,136.00
Spread: 6.00 (0.282%)
Market Cap: £1.41b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

14 Sep 2017 17:30

RNS Number : 8203Q
Genus PLC
14 September 2017
 

14 September 2017

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that yesterday conditional nil-cost share options were granted under the Genus 2014 Performance Share Plan over ordinary shares in Genus to the Executive Directors and members of the Genus Executive Leadership Team ('GELT') as listed in table A below. In addition, following Genus's compulsory deferral requirements relating to the annual bonus earned by Executive Directors and GELT for the financial year ending 30 June 2017, nil-cost share options were granted over ordinary shares under Genus's Deferred Share Bonus Plan as listed in table B below.

Details of the performance conditions that apply to the nil-cost share options can be found in the Directors' Remuneration Report of the Genus 2017 Annual Report.

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the nil-cost share option awards made on 13 September 2017.

 

For further information please contact:

 

Genus:

Cara Crichton, Deputy Company Secretary Tel: +44 (0)1256 347100

 

Table A - GELT 2014 Performance Share Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Karim Bitar

2. Stephen Wilson

3. Bill Christianson

4. Nate Zwald

5. Jerry Thompson

6. Jonathan Lightner

7. Angelle Rosata

8. Dan Hartley

2.

Reason for the notification

a.

Position/status

1. Chief Executive

2. Group Finance Director

3. Chief Operating Officer Genus PIC

4. Chief Operating Officer Genus ABS Dairy

5. Chief Operating Officer Genus ABS Beef

6. Chief Scientific Officer & Head of Genus R&D

7. Group Human Resources Director

8. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under the Genus plc 2014 Performance Share plan over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

Numbers 1 to 8 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

 

Volume(s)

1. 1,972.67p

56,404

2. 1,972.67p

38,221

3. 1,972.67p

22,278

4. 1,972.67p

18,661

5. 1,972.67p

18,661

6. 1,972.67p

22,278

7. 1,972.67p

17,800

8. 1,972.67p

19,009

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2017-09-13

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table B - GELT Deferred Share Bonus Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Karim Bitar

2. Stephen Wilson

3. Bill Christianson

4. Nate Zwald

5. Jerry Thompson

6. Jonathan Lightner

7. Dan Hartley

 

2.

Reason for the notification

a.

Position/status

1. Chief Executive

2. Group Finance Director

3. Chief Operating Officer Genus PIC

4. Chief Operating Officer Genus ABS Dairy

5. Chief Operating Officer Genus ABS Beef

6. Chief Scientific Officer & Head of Genus R&D

7. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Genus's Deferred Share Bonus Plan following the compulsory deferral of 25% of annual bonus in respect of bonuses earned in the financial year ending 30 June 2017.

 

c.

Price(s) and volume(s)

Numbers 1 to 7 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

 

Volume(s)

1. 1,972.67p

20,629

2. 1,972.67p

10,213

3. 1,972.67p

2,017

4. 1,972.67p

557

5. 1,972.67p

615

6. 1,972.67p

7,463

7. 1,972.67p

6,395

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

e.

Date of the transaction

2017-09-13

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUSUNRBKAKAAR
Date   Source Headline
8th Dec 20174:41 pmRNSDirector/PDMR Shareholding
1st Dec 20172:00 pmRNSTotal Voting Rights
23rd Nov 201710:57 amRNSDirector/PDMR Shareholding
17th Nov 20172:15 pmRNSAdditional Listing to Correct Discrepancy
16th Nov 20172:49 pmRNSResult of AGM
16th Nov 20177:00 amRNSAGM Trading Update
6th Nov 201712:48 pmRNSDirector/PDMR Shareholding
2nd Nov 20172:01 pmRNSNon-Executive Director Retirement
1st Nov 20172:00 pmRNSTotal Voting Rights
31st Oct 20177:00 amRNSAdditional Listing
12th Oct 201710:39 amRNSNotice of AGM
2nd Oct 20172:00 pmRNSTotal Voting Rights
29th Sep 20177:08 amRNSDirector Declaration
21st Sep 20175:29 pmRNSDirector/PDMR Shareholding - Replacement
14th Sep 20175:30 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSPreliminary Results
1st Sep 20173:12 pmRNSTotal Voting Rights
17th Aug 20172:51 pmRNSHolding(s) in Company
1st Aug 20172:00 pmRNSTotal Voting Rights
1st Aug 20172:00 pmRNSBlock listing Interim Review
3rd Jul 20172:59 pmRNSTotal Voting Rights
29th Jun 20175:23 pmRNSAdditional Listing
12th Jun 20173:23 pmRNSHolding(s) in Company
9th Jun 20177:00 amRNSUS LITIGATION UPDATE
2nd Jun 20177:00 amRNSTotal Voting Rights
1st Jun 20177:05 amRNSUpdate Regarding The Milk Pension Fund
2nd May 20173:00 pmRNSTotal Voting Rights
12th Apr 20174:48 pmRNSDirector/PDMR Shareholding
3rd Apr 20172:00 pmRNSTotal Voting Rights
3rd Apr 20177:00 amRNSSUCCESSFUL LEGAL OUTCOME FOR GENUS
15th Mar 20175:15 pmRNSDirector/PDMR Shareholding
15th Mar 201712:00 pmRNSDirector Declaration
1st Mar 201710:09 amRNSDirector/PDMR Shareholding
23rd Feb 20174:20 pmRNSCorrection of Record Date
23rd Feb 20177:00 amRNSAcquisition and strategic partnership
23rd Feb 20177:00 amRNSInterim Results
7th Feb 20174:00 pmRNSHolding(s) in Company
1st Feb 20172:00 pmRNSBlock listing Interim Review
13th Dec 20163:39 pmRNSDirector/PDMR Shareholding
1st Dec 20162:00 pmRNSTotal Voting Rights
17th Nov 20162:01 pmRNSResult of AGM
17th Nov 20167:00 amRNSAGM - Trading Update
1st Nov 20164:00 pmRNSTotal Voting Rights
31st Oct 20163:47 pmRNSAnnual Report and Annual General Meeting
26th Oct 20164:00 pmRNSHolding(s) in Company
11th Oct 20164:08 pmRNSDirector/PDMR Shareholding
3rd Oct 20166:09 pmRNSBlock Listing and Additional Listing
3rd Oct 20165:57 pmRNSTotal Voting Rights
29th Sep 20165:00 pmRNSDirector/PDMR Shareholding
15th Sep 20165:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.